These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
The abrdn Life Sciences Investors (NYSE: HQL) is a closed-end fund (CEF) that, as its name indicates, invests primarily in life sciences companies. As of March 31, 2025, the abrdn Life Sciences Investors fund owned 136 stocks. Since its inception, the abrdn Life Sciences Investors fund has delivered an average annual total return (based on its market price) of 8.12%.